Clean Science Q3FY26: EBITDA Falls 27% YoY to ₹722M, Margin Drops to 33%
Clean Science & Technology reported challenging Q3FY26 results with EBITDA declining 27% to ₹722 million and margin compressing to 33% from 40.80% YoY. Net profit fell 30% to ₹518.97 million while revenue dropped 19.9% to ₹1,854.90 million, reflecting difficult market conditions for the specialty chemicals manufacturer.

*this image is generated using AI for illustrative purposes only.
Clean Science & Technology Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showing a decline in both revenue and profitability compared to the previous year. The specialty chemicals manufacturer also declared an interim dividend for shareholders during its board meeting held on January 31, 2026.
Financial Performance Overview
The company's financial performance for Q3FY26 reflected challenging market conditions with significant year-on-year declines across key metrics:
| Metric: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations: | ₹1,854.90 million | ₹2,315.57 million | -19.9% |
| Net Profit: | ₹518.97 million | ₹741.09 million | -30.0% |
| Profit Before Tax: | ₹698.87 million | ₹955.03 million | -26.8% |
| Basic EPS: | ₹4.88 | ₹6.97 | -30.0% |
The company's total income for the quarter decreased to ₹1,943.29 million from ₹2,361.53 million in Q3FY25, representing a decline of 17.7%. Other income increased to ₹88.39 million from ₹45.96 million, providing some offset to the operational revenue decline.
EBITDA Performance Analysis
The company's EBITDA performance showed significant pressure during Q3FY26, reflecting the challenging operating environment:
| EBITDA Metrics: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| EBITDA: | ₹722 million | ₹984 million | -26.6% |
| EBITDA Margin: | 33.00% | 40.80% | -780 bps |
The EBITDA decline of 26.6% to ₹722 million from ₹984 million in Q3FY25 indicates operational challenges beyond just revenue contraction. The EBITDA margin compression to 33% from 40.80% suggests increased cost pressures and reduced operational efficiency during the quarter.
Consolidated Performance Results
On a consolidated basis, Clean Science & Technology reported revenue from operations of ₹2,196.70 million for Q3FY26, compared to ₹2,408.16 million in Q3FY25. The consolidated performance showed similar trends to standalone results:
| Consolidated Metrics: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations: | ₹2,196.70 million | ₹2,408.16 million | -8.8% |
| Net Profit: | ₹459.00 million | ₹656.00 million | -30.0% |
The consolidated net profit of ₹459.00 million represented a 30% decline from ₹656.00 million in the corresponding quarter of the previous year, reflecting the challenging operating environment across the group.
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, Clean Science & Technology demonstrated relatively better performance compared to the quarterly results:
| Parameter: | 9M FY26 | 9M FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations: | ₹6,182.05 million | ₹6,769.30 million | -8.7% |
| Net Profit: | ₹1,930.96 million | ₹2,136.94 million | -9.6% |
| Profit Before Tax: | ₹2,582.21 million | ₹2,854.70 million | -9.5% |
| Basic EPS: | ₹18.17 | ₹20.11 | -9.6% |
The nine-month results showed a more moderate decline, with revenue decreasing 8.7% and net profit falling 9.6% compared to the same period in the previous fiscal year.
Board Meeting Outcomes and Dividend Declaration
The board of directors, in their meeting held on January 31, 2026, approved the unaudited standalone and consolidated financial results and declared an interim dividend of ₹2.00 per equity share (200%) for the financial year 2025-26:
| Dividend Details: | Information |
|---|---|
| Interim Dividend: | ₹2.00 per share (200%) |
| Record Date: | February 6, 2026 |
| Payment Date: | February 23, 2026 |
| Board Meeting Date: | January 31, 2026 |
The dividend will be paid to shareholders whose names appear in the company's register of members as on February 6, 2026, which has been fixed as the record date. During the nine-month period, the company allotted 9,240 equity shares of ₹1 each upon exercise of vested stock options under the Employee Stock Option Scheme 2021 (ESOP 2021).
Historical Stock Returns for Clean Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.26% | -1.96% | -1.13% | -30.47% | -35.36% | -45.69% |


































